Brewin Dolphin LTD Scholar Rock Holding Corp Transaction History

Brewin Dolphin LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 14, 2022	SELL	$4.66 - $13.96 $5,452 - $16,333	-1,170 Closed	0 $0
Q1 2022 Nov 14, 2022	BUY	$11.89 - $24.68 $13,911 - $28,875	1,170 New	1,170 $15,000
Q1 2021 Nov 09, 2023	SELL	$45.96 - $68.02 $19,762 - $29,248	-430 Reduced 26.88%	1,170 $59.3 Million
Q3 2020 Nov 09, 2023	BUY	$10.54 - $18.47 $16,864 - $29,552	1,600 New	1,600 $28.3 Million

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

Stay updated on Brewin Dolphin LTD with notifications on news.